Literature DB >> 11313238

Pharmacologically regulated cell therapy.

T Neff1, C A Blau.   

Abstract

Mesh：

Year:  2001        PMID： 11313238     DOI： 10.1182/blood.v97.9.2535

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  13 in total

1.  JAK2, complemented by a second signal from c-kit or flt-3, triggers extensive self-renewal of primary multipotential hemopoietic cells.

Authors:  Shengming Zhao; Karen Zoller; Masayoshi Masuko; Ponlapat Rojnuckarin; Xuexian O Yang; Evan Parganas; Kenneth Kaushansky; James N Ihle; Thalia Papayannopoulou; Dennis M Willerford; Tim Clackson; C Anthony Blau
Journal:  EMBO J       Date:  2002-05-01       Impact factor: 11.598

Review 2.  Selective expansion of transduced cells for hematopoietic stem cell gene therapy.

Authors:  Akihiro Kume; Yutaka Hanazono; Hiroaki Mizukami; Takashi Okada; Keiya Ozawa
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

Review 3.  Towards in vivo amplification: Overcoming hurdles in the use of hematopoietic stem cells in transplantation and gene therapy.

Authors:  Murtaza S Nagree; Lucía López-Vásquez; Jeffrey A Medin
Journal:  World J Stem Cells       Date:  2015-12-26       Impact factor: 5.326

Review 4.  Survival of the fittest: in vivo selection and stem cell gene therapy.

Authors:  Tobias Neff; Brian C Beard; Hans-Peter Kiem
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

5.  Growth factor receptors as regulators of hematopoiesis.

Authors:  Michael A Weinreich; Ingrid Lintmaer; Linlin Wang; H Denny Liggitt; Michael A Harkey; C Anthony Blau
Journal:  Blood       Date:  2006-08-10       Impact factor: 22.113

Review 6.  Erythropoietic agents and the elderly.

Authors:  Neeraj Agarwal; Josef T Prchal
Journal:  Semin Hematol       Date:  2008-10       Impact factor: 3.851

7.  Long-term regulation of genetically modified primary hematopoietic cells in dogs.

Authors:  Kiyoshi Okazuka; Brian C Beard; David W Emery; Kerstin Schwarzwaelder; Michele R Spector; George E Sale; Christof von Kalle; Beverly Torok-Storb; Hans-Peter Kiem; C Anthony Blau
Journal:  Mol Ther       Date:  2011-02-15       Impact factor: 11.454

8.  Protein interface remodeling in a chemically induced protein dimer.

Authors:  Brian R White; Jonathan C T Carlson; Jessie L Kerns; Carston R Wagner
Journal:  J Mol Recognit       Date:  2012-07       Impact factor: 2.137

Review 9.  Protein engineering for cardiovascular therapeutics: untapped potential for cardiac repair.

Authors:  Steven M Jay; Richard T Lee
Journal:  Circ Res       Date:  2013-09-13       Impact factor: 17.367

10.  Methylguanine methyltransferase-mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model.

Authors:  Tobias Neff; Peter A Horn; Laura J Peterson; Bobbie M Thomasson; Jesse Thompson; David A Williams; Manfred Schmidt; George E Georges; Christof von Kalle; Hans-Peter Kiem
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.